Nanoform Launches Sparse-Data AI Solution

Innovative nanoparticle medicine-enabling company, Nanoform Finland, has launched STARMAP Online—a sparse-data artificial intelligence (AI) solution that it is using as a secure online portal for direct use by the company’s current and future partners.

The company, which announced the launch in a May 4, 2022 press release, has been using the product to provide clients with an assessment of whether their molecules are suitably stable for use with the Controlled Expansion of Supercritical Solutions (CESS) nanoparticle engineering. The AI solution is a digital version of the CESS technology, which provides a determination of whether molecules should be nanoformed through in-silico experiments.

“STARMAP Online opens up new galaxies of potential, and we are excited to increase access for the pharma community. The technology has a significant potential impact, allowing viable CESS candidates to be rapidly identified. STARMAP Online has the potential to transform the lives of patients by accelerating the development of new therapies, supporting our mission to touch the lives of a billion patients with nanoformed medicines,” said Prof. Edward Hæggström, CEO of Nanoform, in the press release.

Source: Nanoform